Brief: Oncozenge Submits Responses To Authorities For Bupizengetm Phase III Trial
02/04/2026 11:57
April 2 (Reuters) - Oncozenge AB ONCOZ.ST: SUBMITS RESPONSES TO AUTHORITIES FOR BUPIZENGETM PHASE III TRIAL EXPECTS CTA APPROVAL DECISION BY LATE APRIL OR EARLY MAY Source text: ID:nMFN5GNhJ1 Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))